Patents Assigned to Dermapharm AG
  • Patent number: 11759348
    Abstract: The invention relates to a device for hyperthermic treatment of itching, for example following insect bites, wherein during the treatment a treatment surface is regulated at a temperature of preferably between 42° C. and 56° C. for a period of 2 sec to 12 sec and a hardware-implemented temperature monitor limits the maximum temperature of the treatment surface and a safety fuse shuts off the device in the case of a short-circuit or uncontrolled continuous heating.
    Type: Grant
    Filed: July 12, 2017
    Date of Patent: September 19, 2023
    Assignee: DERMAPHARM AG
    Inventor: Daniel Bünger
  • Publication number: 20220142813
    Abstract: The invention preferably relates to a device for hyperthermal treatment of itching and/or herpes diseases comprising a control device on which at least two treatment programs are stored and an interface for a selection of one of the at least two treatment programs by means of a mobile device, so that after actuation of an operating element the control device heats a treatment surface according to the selected treatment program to a treatment temperature between 40°-65° C. and holds the treatment temperature for a treatment duration between 1 and 12 seconds.
    Type: Application
    Filed: January 23, 2020
    Publication date: May 12, 2022
    Applicant: DERMAPHARM AG
    Inventor: Daniel BÜNGER VON WURMB
  • Publication number: 20210322205
    Abstract: The invention relates to a device for treating itching and/or herpes disease on a skin, wherein a control device is configured to regulate a treatment surface on an outer side facing the skin by heating at least one heating element in a heating phase to a contact temperature during a contact of the treatment surface with the skin and to maintain the temperature in a treatment phase, and wherein the device comprises at least one contact sensor.
    Type: Application
    Filed: September 5, 2019
    Publication date: October 21, 2021
    Applicant: DERMAPHARM AG
    Inventor: Daniel BÜNGER VON WURMB
  • Publication number: 20210322204
    Abstract: The invention relates a device for the hyperthermal treatment of a herpes disease on a skin, preferably a lip, wherein a control device is configured to regulate a treatment surface on an outer side facing the skin by heating at least one heating element in a heating phase to a contact temperature of 43-47° C. during a contact of the treatment surface with the skin, preferably the lip, and to maintain the contact temperature in a treatment phase for a time period between 1 and 10 seconds.
    Type: Application
    Filed: September 5, 2019
    Publication date: October 21, 2021
    Applicant: DERMAPHARM AG
    Inventor: Daniel BÜNGER VON WURMB
  • Publication number: 20210236327
    Abstract: In a first aspect, the invention relates to a device for hyperthermal treatment of itching comprising at least one treatment surface which can be heated by heating at least one heating element to a treatment temperature of 40° C. to 65° C. and can be controlled by a control device, wherein the device exhibits at least one interface and is configured for a power supply of the device by a mobile device and/or for data exchange with a mobile device and/or for control by a mobile device via the interface. In a further aspect, the invention relates to a system comprising the device and a mobile device, wherein the device is configured for a power supply by the mobile device and/or for data exchange with the mobile device and/or for control by the mobile device via an interface.
    Type: Application
    Filed: June 6, 2019
    Publication date: August 5, 2021
    Applicant: DERMAPHARM AG
    Inventor: Daniel BÜNGER VON WURMB
  • Patent number: D923806
    Type: Grant
    Filed: December 18, 2019
    Date of Patent: June 29, 2021
    Assignee: Dermapharm AG
    Inventors: Daniel Bünger von Wurmb, Josef Prasser
  • Patent number: D930845
    Type: Grant
    Filed: July 23, 2019
    Date of Patent: September 14, 2021
    Assignee: Dermapharm AG
    Inventors: Colin Schmidt, Qiong Zhang
  • Patent number: D963175
    Type: Grant
    Filed: February 2, 2021
    Date of Patent: September 6, 2022
    Assignee: Dermapharm AG
    Inventors: Daniel Bünger von Wurmb, Camill Maier
  • Patent number: D963176
    Type: Grant
    Filed: February 2, 2021
    Date of Patent: September 6, 2022
    Assignee: Dermapharm AG
    Inventors: Daniel Bünger von Wurmb, Camill Maier